Sign In

Login

Password

Forgot Password ? Sign Up

Mazindolo (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mazindolo" in Italian language version.

refsWebsite
Global rank Italian rank
15nih.gov
4th place
9th place
1sigmaaldrich.com
924th place
2,349th place
1oadoi.org
799th place
22nd place
1doi.org
2nd place
7th place

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

  • R. Guazzelli, M. Piazzini; C. Conti; L. Papi; G. Strazzulla; L. Matassi, [Clinical use of mazindol in the treatment of essential obesity]., in Clin Ter, vol. 120, n. 5, Mar 1987, pp. 385-91, PMID 2953538.
  • G. Delitala, S. Alagna; A. Masala, [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity]., in Clin Ter, vol. 81, n. 6, Jun 1977, pp. 547-54, PMID 884939.
  • S. Inoue, M. Egawa; S. Satoh; M. Saito; H. Suzuki; Y. Kumahara; M. Abe; A. Kumagai; Y. Goto; K. Shizume, Clinical and basic aspects of an anorexiant, mazindol, as an antiobesity agent in Japan., in Am J Clin Nutr, vol. 55, 1 Suppl, Jan 1992, pp. 199S-202S, PMID 1728834.
  • JH. Coakley, RH. Edwards; J. Moorcraft; LJ. Hipkin; CS. Smith, Mazindol in Duchenne muscular dystrophy., in Lancet, vol. 1, n. 8578, Jan 1988, p. 184, PMID 2893022.
  • PJ. Collipp, J. Kelemen; SY. Chen; M. Castro-Magana; M. Angulo; A. Derenoncourt, Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy., in J Med Genet, vol. 21, n. 4, Aug 1984, pp. 254-6, PMID 6492089.
  • M. Zatz, M. Vainzof; D. Rapaport; JM. da Rocha; Rde C. Pavanello; RT. Betti, Mazindol and growth hormone inhibition in Duchenne muscular dystrophy., in Am J Med Genet, vol. 27, n. 4, Aug 1987, pp. 993-5, DOI:10.1002/ajmg.1320270433, PMID 3321999.
  • P. Berger, F. Gawin; TR. Kosten, Treatment of cocaine abuse with mazindol., in Lancet, vol. 1, n. 8632, Feb 1989, p. 283, PMID 2563451.
  • JD. Parkes, M. Schachter, Mazindol in the treatment of narcolepsy., in Acta Neurol Scand, vol. 60, n. 4, Oct 1979, pp. 250-4, PMID 525256.
  • J. Shindler, M. Schachter; S. Brincat; JD. Parkes, Amphetamine, mazindol, and fencamfamin in narcolepsy., in Br Med J (Clin Res Ed), vol. 290, n. 6476, Apr 1985, pp. 1167-70, PMID 2859077.
  • B. Alvarez, M. Dahlitz; J. Grimshaw; JD. Parkes, Mazindol in long-term treatment of narcolepsy., in Lancet, vol. 337, n. 8752, maggio 1991, pp. 1293-4, PMID 1674093.
  • S. Iijima, Y. Sugita; Y. Teshima; Y. Hishikawa, Therapeutic effects of mazindol on narcolepsy., in Sleep, vol. 9, 1 Pt 2, 1986, pp. 265-8, PMID 3704452.
  • Z. Rihmer, K. Révai; M. Arató; A. Perényi, Two case reports of mazindol-induced depression., in Am J Psychiatry, vol. 141, n. 11, Nov 1984, pp. 1497-8, PMID 6496806.
  • J. McEwen, RH. Meyboom, Testicular pain caused by mazindol., in Br Med J (Clin Res Ed), vol. 287, n. 6407, Dec 1983, pp. 1763-4, PMID 6416584.
  • C. Sirtori, A. Hurwitz; DL. Azarnoff, Hyperinsulinemia secondary to chronic administration of mazindol and d-amphetamine., in Am J Med Sci, vol. 261, n. 6, Jun 1971, pp. 341-9, PMID 4948438.
  • MS. Hendy, AF. Dove; PG. Arblaster, Mazindol-induced lithium toxicity., in Br Med J, vol. 280, n. 6215, Mar 1980, pp. 684-5, PMID 7363020.

oadoi.org

sigmaaldrich.com